These genetic models have provided many insights into the molecular lesions that can lead to muscular dystrophy; however, real-time monitoring of Dmd expression and localization in vivo, in order to assess both wildtype muscle development and progression of muscle dystrophy at the cellular and protein level, remains a challenge. The gene discussed is DMD; the disease is muscular dystrophy.